NGF-Enhanced Vasculogenic Properties of Epithelial Ovarian Cancer Cells Is Reduced by Inhibition of the COX-2/PGE2 Signaling Axis
Authors:
- Maritza P. GarridoMGMaritza P. Garrido
- Iván HurtadoIHIván Hurtado
- Manuel Valenzuela-ValderramaManuel Valenzuela-Valderrama
- Renato SalvatierraRSRenato Salvatierra
- Andrea HernándezAHAndrea Hernández
- Margarita VegaMVMargarita Vega
- Alberto SelmanASAlberto Selman
- Andrew F. G. QuestAQAndrew F. G. Quest
- Carmen RomeroCarmen Romero
Open Access
Abstract
Epithelial ovarian cancer (EOC) is a lethal gynecological neoplasia characterized by extensive angiogenesis and overexpression of nerve growth factor (NGF). Here, we investigated the mechanism by which NGF increases vascular endothelial growth factor (VEGF) expression and the vasculogenic potential of EOC cells, as well as the contribution of the cyclooxygenase 2/prostaglandin E2 (COX-2/PGE2) signaling axis to these events. EOC biopsies and ovarian cell lines were used to determine COX-2 and PGE2 levels, as well as those of the potentially pro-angiogenic proteins c-MYC (a member of the Myc transcription factors family), survivin, and β-catenin. We observed that COX-2 and survivin protein levels increased during EOC progression. In the EOC cell lines, NGF increased the COX-2 and PGE2 levels. In addition, NGF increased survivin, c-MYC, and VEGF protein levels, as well as the transcriptional activity of c-MYC and β-catenin/T-cell factor/lymphoid enhancer-binding factor (TCF-Lef) in a Tropomyosin receptor kinase A (TRKA)-dependent manner. Also, COX-2 inhibition prevented the NGF-induced increases in these proteins and reduced the angiogenic score of endothelial cells stimulated with conditioned media from EOC cells. In summary, we show here that the pro-angiogenic effect of NGF in EOC depends on the COX-2/PGE2 signaling axis. Thus, inhibition COX-2/PGE2 signaling will likely be beneficial in the treatment of EOC.Keywords
Funding Information
- Fondo Nacional de Desarrollo Científico y Tecnológico (#1160139 (CRO); #1130250 and #1170925 (AFGQ))
- CONICYT-FONDAP (# 15130011)
This publication has 55 references indexed in Scilit:
- Subcellular localization and mechanism of secretion of vascular endothelial growth factor in human skeletal muscleThe FASEB Journal, 2013
- Survivin Status Affects Prognosis and Chemosensitivity in Epithelial Ovarian CancerInternational Journal of Gynecological Cancer, 2013
- Caveolin-1–mediated Suppression of Cyclooxygenase-2 via a β-catenin-Tcf/Lef–dependent Transcriptional Mechanism Reduced Prostaglandin E2 Production and Survivin ExpressionMolecular Biology of the Cell, 2009
- Cyclooxygenases: structural and functional insightsJournal of Lipid Research, 2009
- Wnt signaling in ovarian tumorigenesisInternational Journal of Gynecological Cancer, 2008
- Neurotrophin-regulated signalling pathwaysPhilosophical Transactions of the Royal Society B: Biological Sciences, 2006
- Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancerJournal of Clinical Pathology, 2006
- PGE2 Stimulates VEGF Expression in Endothelial Cells via ERK2/JNK1 Signaling PathwaysBiochemical and Biophysical Research Communications, 2001
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- c-myc amplification in ovarian cancerGynecologic Oncology, 1990